Perimenopausal women show approximately twice the odds of poor cardiovascular health scores compared to premenopausal women, with particularly sharp declines in blood lipid and glucose profiles. This transition window represents a critical intervention opportunity before postmenopausal risk becomes established.
Key Points
- Perimenopausal stage shows sharpest cardiovascular decline relative to age
- Blood lipid and glucose dysregulation accelerate during perimenopause by 76–83%
- Dietary quality consistently scores lowest across all menopausal stages
Longevity Analysis
The perimenopause window identifies when hormonal changes trigger measurable cardiometabolic deterioration—not as an inevitable consequence of aging, but as a physiologically specific period when intervention can reset trajectory. Early detection of blood pressure, lipid, and glucose patterns before they crystallize into postmenopausal risk allows practitioners to address the upstream drivers of cardiovascular disease rather than managing its consequences. Nutritional optimization, in particular, emerges as a leverage point during this transition, since dietary patterns show consistent impairment yet remain modifiable through deliberate practice.
Original published by LifeSpan.io, by Anna Drangowska-Way.